Florence Healthcare has released its annual State of Clinical Trial Operations Technology Report. More than 190 clinical operations leaders from across the drug development lifecycle contributed to this year’s report, revealing their thoughts and recommendations for the next year of technology transformation in the industry.
Key findings from the survey include:
- 61% of all respondents believe managing clinical trial operations in one platform is extremely important, while 66% of sponsors say eliminating paper from their operations is a top reason for investing in technology.
- 89% of sponsors indicate they use elements of decentralized clinical trials (DCT) in their trials, with hospitals and health systems the highest adopters of DCT elements, at 92%.
- 89% of sites intend to have an electronic investigator site file (eISF) in place by the end of 2022, and 88% expect to use eConsent for patient-informed consent.
- 72% of sites make technology decisions based on how much repetitive work a new technology eliminates.
Access additional information and the full report here.